|
TXLNA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.397230E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.719000E-01 |
| Normal-vs-Stage2 |
5.694600E-01 |
| Normal-vs-Stage3 |
1.270150E-01 |
| Normal-vs-Stage4 |
9.226400E-01 |
| Stage1-vs-Stage2 |
9.515800E-01 |
| Stage1-vs-Stage3 |
2.873400E-01 |
| Stage1-vs-Stage4 |
6.405600E-01 |
| Stage2-vs-Stage3 |
4.751200E-01 |
| Stage2-vs-Stage4 |
6.489800E-01 |
| Stage3-vs-Stage4 |
3.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.304800E-01 |
| Normal-vs-AfricanAmerican |
4.756000E-01 |
| Normal-vs-Asian |
7.032000E-01 |
| Caucasian-vs-AfricanAmerican |
8.834400E-01 |
| Caucasian-vs-Asian |
9.064200E-01 |
| AfricanAmerican-vs-Asian |
9.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.076600E-01 |
| Normal-vs-Female |
3.725900E-02 |
| Male-vs-Female |
1.933420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.598400E-01 |
| Normal-vs-Extreme_Weight |
7.564400E-01 |
| Normal-vs-Obese |
2.464400E-01 |
| Normal-vs-Extreme_Obese |
4.003200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.231800E-01 |
| Normal_Weight-vs-Obese |
6.648600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.992400E-01 |
| Extreme_Weight-vs-Obese |
3.563800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.377200E-01 |
| Obese-vs-Extreme_Obese |
5.827800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.891600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.490100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.895000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.868000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.375800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.562000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.817400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.947620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.031800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.931800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.070590E-01 |
| Normal-VS-Type2 PRCC |
8.605000E-01 |
| Normal-VS-KIRP CIMP |
1.574230E-02 |
| Normal-VS-Unclassified PRCC |
1.018950E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.062850E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.242000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.590000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.424000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.150030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.031800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.574200E-01 |
| Normal-vs-N1 |
2.788000E-01 |
| Normal-vs-N2 |
7.901200E-01 |
| N0-vs-N1 |
6.296200E-01 |
| N0-vs-N2 |
9.471200E-01 |
| N1-vs-N2 |
8.956600E-01 |
|
|
